by Mark Dunning
Original article appeared on Usher Syndrome Coalition Website
Thanks to genetic testing, we are now able to identify children with all types of Usher syndrome at a much younger age.
Read It is a fact that to date there are no cures or therapies for retinitis pigmentosa.
We have collected in this article all the treatments that circulate on the web, but in the same article it reads:
There are no univocal scientific confirmations.
Read International
Usher Syndrome Coalition. The Usher Syndrome Coalition’s mission is to raise awareness and accelerate research for the most common genetic cause of combined deafness and blindness.
Read In the month of August 2019 a very interesting and important research study on the life strategies of people with Usher Syndrome type 2A was published in Sweden.
Read On December 2nd Retina International sent the RI USH SIG Winter Newsletter
We are happy to send you the RI USH SIG Winter Newsletter providing you with an update of the latest and upcoming news relevant for people living with Usher Syndrome and with a resource file on USH subtypes, genetic testing and USH genes.
Read Inspired by putting visually imparied people first, Reader-view creates a new way to search the internet.
Typically when people search the web for content to read, the process consists of two separate tasks: guessing which link is going to be the best one to click, and then reading the articles.
Read ProQR is developing a novel investigational drug called QR-421a to treat RP in patients that have USH2 due to a mutation in a specific part of the USH2A gene, called exon 13.
Read Tales in Sombre Tones is an exciting new touring show with the specific aim of opening up art and literature for all.
Read RI USH SIG launches newsletter
Retina International’s Special Interest Group for Usher Syndrome (RI USH SIG) has launched their newsletter to share up-to-date information on Usher Syndrome advances around the world.
Read